Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:59 AM
Ignite Modification Date: 2025-12-25 @ 11:12 PM
NCT ID: NCT01859793
Description: None
Frequency Threshold: 0
Time Frame: 3 years
Study: NCT01859793
Study Brief: Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Matching Placebo Matching Placebo for Sitagliptin Placebo: Matching placebo in appearance given once/day orally None None 0 36 1 36 View
Sitagliptin 100mg pill, PO administered once daily. sitagliptin: 100 mg pill, administered once/day orally None None 0 32 0 32 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Rash NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View